Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:32 PM
Ignite Modification Date:
2025-12-24 @ 9:32 PM
NCT ID:
NCT00149032
Eligibility Criteria:
Inclusion Criteria:
* Patients with hematologic malignancy or metastatic solid tumor relapsing following allogeneic bone marrow or blood stem cell transplantation (alloBMT) or non-myeloablative stem cell transplantation resistant to DLI with no GVHD when taken off anti-GVHD prophylaxis.
* Patients with documented chimerism to confirm induction of host-vs-graft transplantation tolerance.
Exclusion Criteria:
* Patients not consenting to participate in the study, or minors without approved parental consent.
* Patients with other diseases or complications that may limit their life span other than their basic disease.
* Pregnant or lactating women.
* Non-compliant patients or patients with poor performance status with life expectancy, e.g. 6 weeks.
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT00149032
Study Brief:
Protocol Section:
NCT00149032